Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
paper
Cited
Public
Unavailable
- Authors
- Hildebrand, B E; Nomikos, G G; Hertel, P; SchilstrΓΆm, B; Svensson, T H
- Year
- 1998
- Journal
- Brain research
- PMID
- 9473676
- DOI
- 10.1016/s0006-8993(97)01135-9
Mesolimbocortical dopamine (DA) neurotransmission is important in the mediation of the dependence-producing actions of nicotine and other drugs of abuse. Withdrawal from chronic treatment with various types of addictive drugs, including amphetamine, cocaine, ethanol and morphine is associated with a decrease in dopaminergic output in the nucleus accumbens (NAC), whereas the effects of withdrawal from these drugs on dopaminergic output in the medial prefrontal cortex (PFC), as yet, remain largely unknown. This study examined putative changes in the extracellular levels of dopamine and its metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the NAC and in the PFC of rats displaying behavioral signs of nicotine withdrawal. Rats were infused for 7 days with nicotine via subcutaneously implanted minipumps, whereas control animals carried saline-containing pumps. On the fifth day of infusion a microdialysis probe was implanted in the NAC or the PFC of the rats. Forty-eight hours later the levels of DA and the monoamine metabolites were assessed in the dialysate. The behavioral and biochemical effects of a saline injection and a subsequent challenge with the nicotinic receptor antagonist mecamylamine (1 mg/kg s.c.) were determined. Following mecamylamine challenge in nicotine-treated animals, the levels of DA, DOPAC and HVA in the NAC, but not in the PFC, decreased below pre-injection levels and in relation to control animals. The score of abstinence signs increased in the nicotine-treated rats, as compared both to the score after saline and to that in control animals. The decreased DA output in the NAC in animals displaying nicotine withdrawal signs is similar to that seen after withdrawal of several other drugs of abuse, and may have bearing on motivational deficits associated with the abstinence reactions.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke. | 2017 | 27067016 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Adolescent nicotine abstinence increases anxiety and depressive-like behaviors, alcohol consumption, oxidative stress and inflammatory response accompanied by attenuated serotonergic/dopaminergic and cholinergic function in rats. | Ahmadi-Soleimani SM et al. | β | 2025 | β |
| Nicotine Withdrawal Drives Aversive Behaviors by Recruiting Inhibitory Interpeduncular Nucleus Inputs to the Laterodorsal Tegmentum in Mice. | Monical A et al. | β | 2025 | β |
| CHRNA5 gene variation affects the response of VTA dopaminergic neurons during chronic nicotine exposure and withdrawal. | Yang K et al. | β | 2023 | β |
| The Role of Dopamine D3 Receptors in Tobacco Use Disorder: A Synthesis of the Preclinical and Clinical Literature. | Butler K et al. | β | 2023 | β |
| Neurobiological Mechanisms of Nicotine Reward and Aversion. | Wills L et al. | β | 2022 | β |
| Addiction-related neuroadaptations following chronic nicotine exposure. | Wills L et al. | β | 2021 | β |
| Multifactorial Etiology of Adolescent Nicotine Addiction: A Review of the Neurobiology of Nicotine Addiction and Its Implications for Smoking Cessation Pharmacotherapy. | Mahajan SD et al. | β | 2021 | β |
| Glial cells as therapeutic targets for smoking cessation. | Kumar M et al. | β | 2020 | β |
| One Is Not Enough: Understanding and Modeling Polysubstance Use. | Crummy EA et al. | β | 2020 | β |
| Dopamine and addiction: what have we learned from 40Β years of research. | Solinas M et al. | β | 2019 | β |
| Amino acid modulation of dopamine in the nucleus accumbens mediates sex differences in nicotine withdrawal. | Carcoba LM et al. | β | 2018 | β |
| Molecular, Neuronal, and Behavioral Effects of Ethanol and Nicotine Interactions. | Klenowski PM et al. | β | 2018 | β |
| Nicotine and sleep deprivation: impact on pain sensitivity and immune modulation in rats. | Hirotsu C et al. | β | 2018 | β |
| A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke. | Jensen KP et al. | β | 2017 | β |
| Neuropeptide systems and new treatments for nicotine addiction. | Bruijnzeel AW | β | 2017 | β |
| A novel method to induce nicotine dependence by intermittent drug delivery using osmotic minipumps. | Brynildsen JK et al. | β | 2016 | β |
| Drug addiction: An affective-cognitive disorder in need of a cure. | Fattore L et al. | β | 2016 | β |
| Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications. | D'Souza MS | β | 2016 | β |
| Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats. | Qi X et al. | β | 2016 | β |
| Varenicline-Induced Elevation of Dopamine in Smokers: A Preliminary [(11)C]-(+)-PHNO PET Study. | Di Ciano P et al. | β | 2016 | β |
| Chronic cocaine disrupts mesocortical learning mechanisms. | Buchta WC et al. | β | 2015 | β |
| Does incentive-elicited nucleus accumbens activation differ by substance of abuse? An examination with adolescents. | Karoly HC et al. | β | 2015 | β |
| Effect of prenatal stress on memory, nicotine withdrawal and 5HT1A expression in raphe nuclei of adult rats. | Said N et al. | β | 2015 | β |
| Inhibition of monoacylglycerol lipase reduces nicotine withdrawal. | Muldoon PP et al. | β | 2015 | β |
| Is impulsivity a symptom of initial tobacco withdrawal? A meta-analysis and qualitative systematic review. | Hughes JR et al. | β | 2015 | β |
| Nicotine withdrawal. | McLaughlin I et al. | β | 2015 | β |
| Nicotinic, glutamatergic and dopaminergic synaptic transmission and plasticity in the mesocorticolimbic system: focus on nicotine effects. | Pistillo F et al. | β | 2015 | β |
| Smoking abstinence and neurocognition: implications for cessation and relapse. | McClernon FJ et al. | β | 2015 | β |
| The role of mesoaccumbens dopamine in nicotine dependence. | Balfour DJ | β | 2015 | β |
| A mechanistic hypothesis of the factors that enhance vulnerability to nicotine use in females. | O'Dell LE et al. | β | 2014 | β |
| Baclofen prevented the changes in c-Fos and brain-derived neutrophic factor expressions during mecamylamine-precipitated nicotine withdrawal in mice. | Varani AP et al. | β | 2014 | β |
| Cholinergic transmission during nicotine withdrawal is influenced by age and pre-exposure to nicotine: implications for teenage smoking. | Carcoba LM et al. | β | 2014 | β |
| Examination of the effects of varenicline, bupropion, lorcaserin, or naltrexone on responding for conditioned reinforcement in nicotine-exposed rats. | Guy EG et al. | β | 2014 | β |
| Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation. | Li X et al. | β | 2014 | β |
| Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems. | Mackowick KM et al. | β | 2014 | β |
| Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking. | Cohen A et al. | β | 2013 | β |
| Beta2-containing nicotinic acetylcholine receptors mediate calcium/calmodulin-dependent protein kinase-II and synapsin I protein levels in the nucleus accumbens after nicotine withdrawal in mice. | Jackson KJ et al. | β | 2013 | β |
| Implicit and explicit reward learning in chronic nicotine use. | Paelecke-Habermann Y et al. | β | 2013 | β |
| Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat. | Malin DH et al. | β | 2013 | β |
| Mecamylamine-precipitated nicotine withdrawal syndrome and its prevention with baclofen: an autoradiographic study of Ξ±4Ξ²2 nicotinic acetylcholine receptors in mice. | Varani AP et al. | β | 2013 | β |
| Ro 32-0432 attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice. | Singh TG et al. | β | 2013 | β |
| The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence. | Muldoon PP et al. | β | 2013 | β |
| Adolescent rats are resistant to adaptations in excitatory and inhibitory mechanisms that modulate mesolimbic dopamine during nicotine withdrawal. | Natividad LA et al. | β | 2012 | β |
| Attention deficit hyperactivity disorder and substance use disorders. | Bukstein OG | β | 2012 | β |
| Dysregulation of kappa-opioid receptor systems by chronic nicotine modulate the nicotine withdrawal syndrome in an age-dependent manner. | Tejeda HA et al. | β | 2012 | β |
| Effects of calcium channel antagonists on the motivational effects of nicotine and morphine in conditioned place aversion paradigm. | Budzynska B et al. | β | 2012 | β |
| Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal. | Radke AK et al. | β | 2012 | β |
| Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies. | El Khoury MA et al. | β | 2012 | β |
| Shifting pharmacology of nicotine use and withdrawal: breaking the cycle of drug abuse. | Sesia T et al. | β | 2012 | β |
| Smoking, quitting, and psychiatric disease: a review. | Aubin HJ et al. | β | 2012 | β |
| Ξ±3Ξ²4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine inΒ vivo. | McCallum SE et al. | β | 2012 | β |
| Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal. | Varani AP et al. | β | 2011 | β |
| Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats. | Ohmura Y et al. | β | 2011 | β |
| Enhanced dopamine transporter function in striatum during nicotine withdrawal. | Hadjiconstantinou M et al. | β | 2011 | β |
| Exploring behavioral and molecular mechanisms of nicotine reward in adolescent mice. | Kota D et al. | β | 2011 | β |
| Historical and current perspective on tobacco use and nicotine addiction. | Dani JA et al. | β | 2011 | β |
| L-DOPA attenuates nicotine withdrawal-induced behaviors in rats. | Ohmura Y et al. | β | 2011 | β |
| Mechanistic insights into nicotine withdrawal. | Paolini M et al. | β | 2011 | β |
| Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. | D'Souza MS et al. | β | 2011 | β |
| Nicotine and endogenous opioids: neurochemical and pharmacological evidence. | Hadjiconstantinou M et al. | β | 2011 | β |
| Reward, addiction, withdrawal to nicotine. | De Biasi M et al. | β | 2011 | β |
| Translational research in addiction: toward a framework for the development of novel therapeutics. | Paterson NE | β | 2011 | β |
| Behavioral effects of nicotine withdrawal differ by genetic strain in male and female adolescent rats. | Hamilton KR et al. | β | 2010 | β |
| Dopaminergic signaling mediates the motivational response underlying the opponent process to chronic but not acute nicotine. | Grieder TE et al. | β | 2010 | β |
| Neural substrates of psychostimulant withdrawal-induced anhedonia. | D'Souza MS et al. | β | 2010 | β |
| Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male rats. | Natividad LA et al. | β | 2010 | β |
| The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats. | Semenova S et al. | β | 2010 | β |
| Waterpipe tobacco smoking: an emerging health crisis in the United States. | Cobb C et al. | β | 2010 | β |
| A psychobiological framework of the substrates that mediate nicotine use during adolescence. | O'Dell LE | β | 2009 | β |
| Behavioral effects of nicotine withdrawal in adult male and female rats. | Hamilton KR et al. | β | 2009 | β |
| Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: recent preclinical and clinical insights. | Paterson NE | β | 2009 | β |
| Increased expression of VMAT2 in dopaminergic neurons during nicotine withdrawal. | Duchemin AM et al. | β | 2009 | β |
| Mechanism-based medication development for the treatment of nicotine dependence. | Xi ZX et al. | β | 2009 | β |
| Rodent models of nicotine withdrawal syndrome. | Malin DH et al. | β | 2009 | β |
| The neuronal pathways mediating the behavioral and addictive properties of nicotine. | Balfour DJ | β | 2009 | β |
| The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal. | Jackson KJ et al. | β | 2009 | β |
| Convergence and divergence in the etiology of myelin impairment in psychiatric disorders and drug addiction. | Feng Y | β | 2008 | β |
| Dynorphin and prodynorphin mRNA changes in the striatum during nicotine withdrawal. | Isola R et al. | β | 2008 | β |
| Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. | McClernon FJ et al. | β | 2008 | β |
| Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal. | De Biasi M et al. | β | 2008 | β |
| Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation. | Tutka P | β | 2008 | β |
| Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies. | Liechti ME et al. | β | 2008 | β |
| TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity. | Lippiello PM et al. | β | 2008 | β |
| Ventral striatal blood flow is altered by acute nicotine but not withdrawal from nicotine. | Tanabe J et al. | β | 2008 | β |
| Adolescent nicotine exposure produces less affective measures of withdrawal relative to adult nicotine exposure in male rats. | O'Dell LE et al. | β | 2007 | β |
| Animal models and treatments for addiction and depression co-morbidity. | Paterson NE et al. | β | 2007 | β |
| Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. | Paterson NE et al. | β | 2007 | β |
| Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit. | Salas R et al. | β | 2007 | β |
| Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal. | Wing VC et al. | β | 2007 | β |
| Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors. | SchilstrΓΆm B et al. | β | 2007 | β |
| Guidelines on nicotine dose selection for in vivo research. | Matta SG et al. | β | 2007 | β |
| Metabotropic glutamate 2/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats. | Liechti ME et al. | β | 2007 | β |
| Nicotine dependence and reward differ between adolescent and adult male mice. | Kota D et al. | β | 2007 | β |
| The ability of the mesocortical dopamine system to operate in distinct temporal modes. | Lapish CC et al. | β | 2007 | β |
| The smoking Stroop and delay discounting in smokers: effects of environmental smoking cues. | Field M et al. | β | 2007 | β |
| Attenuation of nicotine-induced rewarding effects in A2A knockout mice. | CastaΓ±Γ© A et al. | β | 2006 | β |
| Bupropion attenuates nicotine abstinence syndrome in the rat. | Malin DH et al. | β | 2006 | β |
| Delay discounting and the behavioural economics of cigarette purchases in smokers: the effects of nicotine deprivation. | Field M et al. | β | 2006 | β |
| Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction. | O'Dell LE et al. | β | 2006 | β |
| Neuropharmacology and potential efficacy of new treatments for tobacco dependence. | FagerstrΓΆm K et al. | β | 2006 | β |
| Acetylcholine in the accumbens is decreased by diazepam and increased by benzodiazepine withdrawal: a possible mechanism for dependency. | Rada P et al. | β | 2005 | β |
| A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature. | DiFranza JR et al. | β | 2005 | β |
| Blockade of the expression of mecamylamine-precipitated nicotine withdrawal by calcium channel antagonists. | Biala G et al. | β | 2005 | β |
| Deficits in a sustained attention task following nicotine withdrawal in rats. | Shoaib M et al. | β | 2005 | β |
| Effects of alpha4beta2 and alpha7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats. | Motoshima S et al. | β | 2005 | β |
| The dopamine hypothesis of drug addiction: hypodopaminergic state. | Melis M et al. | β | 2005 | β |
| Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats. | Bruijnzeel AW et al. | β | 2004 | β |
| Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice. | Balerio GN et al. | β | 2004 | β |
| Imaging localised dynamic changes in the nucleus accumbens following nicotine withdrawal in rats. | Shoaib M et al. | β | 2004 | β |
| Measuring the emergence of tobacco dependence: the contribution of negative reinforcement models. | Eissenberg T | β | 2004 | β |
| Neuroendocrinological and neuropsychological correlates of dopaminergic function in nicotine dependence. | Smolka MN et al. | β | 2004 | β |
| Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. | Sacco KA et al. | β | 2004 | β |
| The principal features and mechanisms of dopamine modulation in the prefrontal cortex. | Seamans JK et al. | β | 2004 | β |
| Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. | Cryan JF et al. | β | 2003 | β |
| Bupropion-induced somnambulism. | Khazaal Y et al. | β | 2003 | β |
| Impact of nicotine withdrawal on novelty reward and related behaviors. | Besheer J et al. | β | 2003 | β |
| The neurobiology of addiction. | Maldonado R | β | 2003 | β |
| [Involvement of neuronal nicotinic receptor in psychiatric disorders]. | Suemaru K et al. | β | 2002 | β |
| Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. | CastaΓ±Γ© A et al. | β | 2002 | β |
| Mecamylamine decreases accumbal dopamine output in mice treated chronically with nicotine. | GΓ€ddnΓ€s H et al. | β | 2002 | β |
| Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine. | Araki H et al. | β | 2002 | β |
| Nicotine withdrawal syndrome: behavioural distress and selective up-regulation of the cyclic AMP pathway in the amygdala. | Tzavara ET et al. | β | 2002 | β |
| The potential of dopamine agonists in drug addiction. | Kosten TR et al. | β | 2002 | β |
| Enhanced motor activity and brain dopamine turnover in mice during long-term nicotine administration in the drinking water. | GΓ€ddnΓ€s H et al. | β | 2001 | β |
| Neurobiology of the nicotine withdrawal syndrome. | Kenny PJ et al. | β | 2001 | β |
| Nicotine dependence: studies with a laboratory model. | Malin DH | β | 2001 | β |
| Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens. | Schmidt BL et al. | β | 2001 | β |
| Pharmacology and behavioral pharmacology of the mesocortical dopamine system. | Tzschentke TM | β | 2001 | β |
| A rodent model of cocaine abstinence syndrome. | Malin DH et al. | β | 2000 | β |
| Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness. | Nomikos GG et al. | β | 2000 | β |
| Role of dopamine in the behavioural actions of nicotine related to addiction. | Di Chiara G | β | 2000 | β |
| Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. | Panagis G et al. | β | 2000 | β |
| The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction? | Balfour DJ et al. | β | 2000 | β |
| The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. | Balfour DJ et al. | β | 2000 | β |
| Mecamylamine-precipitated nicotine-withdrawal aversion in Lewis and Fischer 344 inbred rat strains. | Suzuki T et al. | β | 1999 | β |
| Nicotine abstinence in the mouse. | Isola R et al. | β | 1999 | β |
| Presynaptic ionotropic receptors and the control of transmitter release. | MacDermott AB et al. | β | 1999 | β |
| Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress. | George TP et al. | β | 1998 | β |